Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to assess neuroimaging markers that have previously been shown to be involved in chronic pain.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for QST:
Exclusion Criteria for QST:
Additional Inclusion Criteria for neuroimaging:
Additional Exclusion Criteria for neuroimaging:
125 participants in 1 patient group
Loading...
Central trial contact
Mary Carns, MS; Kathleen Aren, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal